Lobbying disclosures · Lobbying report
COR: third_quarter 2026 lobbying report
Issues related to the pharmaceutical supply chain, drug shortages, and national stockpiles. Issues related to the role and value of community specialty physicians. Issues related to the pharmaceutical supply chain, drug shortages, and national stockpiles. Issues related to drug shortages and national stockpiles at the U. S. Department of War. Issues related to corporate taxation. Issues related to reimbursement and Medicare Part B.
Follow COR- Became public
- Oct 13, 2026, 11:11 AM EDT
- Event / period date
- Not stated
- Collected
- Nov 11, 2026, 12:48 AM EST
Why this is connected
Legal-name match: CENCORA INC. (FORMERLY AMERISOURCEBERGEN CORPORATION) is Cencora, Inc. (https://www.sec.gov/Archives/edgar/data/1140859/), differing only in punctuation, "the" or suffix spelling (Corp/Corporation).
Reported lobbying amounts
Income: $60,000.00
These are different reporting measures. They are not added together or treated as spending on one particular bill.
Source evidence
Read the source excerpt or record
{"url":"https://lda.gov/api/v1/filings/820724cc-472e-42b7-af5b-88c76ac03a21/","filing_uuid":"820724cc-472e-42b7-af5b-88c76ac03a21","filing_type":"Q3","filing_type_display":"3rd Quarter - Report","filing_year":2026,"filing_period":"third_quarter","filing_period_display":"3rd Quarter (July 1 - Sep 30)","filing_document_url":"https://lda.gov/filings/public/filing/820724cc-472e-42b7-af5b-88c76ac03a21/print/","filing_document_content_type":"text/html","income":"60000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Teresa Schofield","dt_posted":"2026-10-13T11:11:46-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"607 - 14th Street NW","registrant_address_2":"Suite 750","registrant_different_address":true,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20005","registrant":{"id":320918,"url":"https://lda.gov/api/v1/registrants/320918/","house_registrant_id":39554,"name":"KOUNTOUPES DENHAM CARR & REID, LLC","description":"Federal lobbying and consulting services","address_1":"607 - 14th Street NW","address_2":"Suite 750","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20005","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"NANCY HARPER MARLOW","contact_telephone":"+1 202-803-4585","dt_updated":"2026-07-22T14:29:32.717701-04:00"},"client":{"id":186716,"url":"https://lda.gov/api/v1/clients/186716/","client_id":1005371,"name":"CENCORA INC. (FORMERLY AMERISOURCEBERGEN CORPORATION)","general_description":"Pharmaceutical Distributor","client_government_entity":false,"client_self_select":null,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2018-04-18"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Issues related to the pharmaceutical supply chain, drug shortages, and national stockpiles. Issues related to the role and value of community specialty physicians.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":45200,"prefix":null,"prefix_display":null,"first_name":"LORI","nickname":null,"middle_name":null,"last_name":"DENHAM","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":10646,"prefix":null,"prefix_display":null,"first_name":"JULIE","nickname":null,"middle_name":"HERSHEY","last_name":"CARR","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141462,"prefix":"ms","prefix_display":"MS.","first_name":"MARY","nickname":null,"middle_name":"DEE","last_name":"BEAL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":144880,"prefix":null,"prefix_display":null,"first_name":"LESLIE","nickname":null,"middle_name":null,"last_name":"ZELENKO","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"PHA","general_issue_code_display":"Pharmacy","description":"Issues related to the pharmaceutical supply chain, drug shortages, and national stockpiles.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":45200,"prefix":null,"prefix_display":null,"first_name":"LORI","nickname":null,"middle_name":null,"last_name":"DENHAM","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":10646,"prefix":null,"prefix_display":null,"first_name":"JULIE","nickname":null,"middle_name":"HERSHEY","last_name":"CARR","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141462,"prefix":"ms","prefix_display":"MS.","first_name":"MARY","nickname":null,"middle_name":"DEE","last_name":"BEAL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":144880,"prefix":null,"prefix_display":null,"first_name":"LESLIE","nickname":null,"middle_name":null,"last_name":"ZELENKO","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"DEF","general_issue_code_display":"Defense","description":"Issues related to drug shortages and national stockpiles at the U. S. Department of War.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":45200,"prefix":null,"prefix_display":null,"first_name":"LORI","nickname":null,"middle_name":null,"last_name":"DENHAM","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[]},{"general_issue_code":"TAX","general_issue_code_display":"Taxation/Internal Revenue Code","description":"Issues related to corporate taxation.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":45200,"prefix":null,"prefix_display":null,"first_name":"LORI","nickname":null,"middle_name":null,"last_name":"DENHAM","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":72966,"prefix":null,"prefix_display":null,"first_name":"ADAM","nickname":null,"middle_name":null,"last_name":"HECHAVARRIA","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"Issues related to reimbursement and Medicare Part B.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":10646,"prefix":null,"prefix_display":null,"first_name":"JULIE","nickname":null,"middle_name":"HERSHEY","last_name":"CARR","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}Congressional trading in COR
These disclosures provide context. Their presence does not establish a link between a trader and the event.
- Nov 5, 2026$1K–$15K
Rep. Ro Khanna (D-CA-17)
$1K–$15K · Traded Oct 7, 2026 · disclosed Nov 5, 2026 · Spouse
Traded 14 days before earnings - Oct 7, 2026$1K–$15K
Rep. Ro Khanna (D-CA-17)
$1K–$15K · Traded Sep 4, 2026 · disclosed Oct 7, 2026 · Spouse
- Jul 21, 2026$1K–$15K
Sen. Alan Armstrong (R-OK)
$1K–$15K · Traded Mar 27, 2026 · disclosed Jul 21, 2026 · filed 116 days later
Committee overlap: HELP - Jun 19, 2026$1K–$15K
Rep. Jared Moskowitz (D-FL-23)
$1K–$15K · Traded May 6, 2026 · disclosed Jun 19, 2026
Got $1K from the company’s PAC - Jun 19, 2026$1K–$15K
Rep. Jared Moskowitz (D-FL-23)
$1K–$15K · Traded May 6, 2026 · disclosed Jun 19, 2026 · Dependent
Got $1K from the company’s PAC - Apr 30, 2026$1K–$15K
Rep. Jared Moskowitz (D-FL-23)
$1K–$15K · Traded Mar 31, 2026 · disclosed Apr 30, 2026
Got $1K from the company’s PAC - Apr 30, 2026$1K–$15K
Rep. Jared Moskowitz (D-FL-23)
$1K–$15K · Traded Mar 23, 2026 · disclosed Apr 30, 2026
Got $1K from the company’s PAC - Apr 30, 2026$1K–$15K
Rep. Jared Moskowitz (D-FL-23)
$1K–$15K · Traded Mar 23, 2026 · disclosed Apr 30, 2026 · Dependent
Got $1K from the company’s PAC
Original documents control. Public records can be amended, and company connections may require interpretation. Nothing here is investment advice.